Page 57 - HIV/AIDS Guidelines

71. Shiels MS, Pfeiffer RM, Hall HI, et al. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical
cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA. Apr 13 2011;305(14):1450-1459.
72. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the
general population in the United States, 1992-2003. Ann Intern Med. May 20 2008;148(10):728-736.
73. Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired
immunodeficiency syndrome in the United States. Cancer. Mar 1 2011;117(5):1089-1096.
74. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl
Cancer Inst. May 4 2011;103(9):753-762.
75. Ellis RJ, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated
in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research
Center Group. Ann Neurol. Nov 1997;42(5):679-688.
76. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated
dementia and viral load in cerebrospinal fluid and brain. Ann Neurol. Nov 1997;42(5):689-698.
77. Spudich SS, Huang W, Nilsson AC, et al. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and
plasma samples: a survey of subjects with viremia. J Infect Dis. Mar 15 2005;191(6):890-898.
78. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. Jun 1986;19(6):517-524.
79. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis. Nov 1988;158(5):1079-1083.
80. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders.
Neurology. Oct 30 2007;69(18):1789-1799.
81. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune
deficiency syndrome: analysis of 50 patients. Ann Neurol. Oct 1983;14(4):403-418.
82. d'Arminio Monforte A, Cinque P, Mocroft A, et al. Changing incidence of central nervous system diseases in the
EuroSIDA cohort. Ann Neurol. Mar 2004;55(3):320-328.
83. Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of human immunodeficiency virus-
associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. Feb 2008;63(2):213-221.
84. Lescure F-X, Omland LH, Engsig FN, et al. Incidence and impact on mortality of severe neuro-cognitive disorders in
persons with and without HIV: a Danish nationwide cohort study. Clinical Infectious Diseases. 2010: Jan. 15
2011;52(2):235-243.
85. Mellgren A, Antinori A, Cinque P, et al. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral
treatment. Antivir Ther. 2005;10(6):701-707.
86. Spudich S, Lollo N, Liegler T, Deeks SG, Price RW. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting
of systemic virological suppression and failure. J Infect Dis. Dec 15 2006;194(12):1686-1696.
87. Canestri A, Lescure FX, Jaureguiberry S, et al. Discordance between cerebral spinal fluid and plasma HIV replication in
patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. Jan 25
2010;50(5):773-778.
88. Eden A, Fuchs D, Hagberg L, et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral
treatment. J Infect Dis. Dec 15 2010;202(12):1819-1825.
89. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of
viremia. AIDS. Jun 1 2010;24(9):1243-1250.
90. Smurzynski M, Wu K, Letendre S, et al. Effects of central nervous system antiretroviral penetration on cognitive
functioning in the ALLRT cohort. AIDS. Jan 28 2011;25(3):357-365.
91. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, et al. Nadir CD4 cell count predicts neurocognitive impairment in HIV-
infected patients. AIDS Res Hum Retroviruses. Oct 2008;24(10):1301-1307.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents E-16

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.